What is CVE-2024-53522?

CVE-2024-53522 is a high-severity vulnerability in N/a, classified under Insufficient Entropy. CVSS score: 7.5/10. Published 2025-01-07.

How severe is CVE-2024-53522?

High severity. CVSS v3 base score is 7.5 out of 10.

Is CVE-2024-53522 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Vulnerability in N/a

CVE-2024-53522

Bangkok Medical Software HOSxP XE v4.64.11.3 was discovered to contain a hardcoded IDEA Key-IV pair in the HOSxPXE4.exe and HOS-WIN32.INI components. This allows attackers to access sensitive information.

EPSS: 0.007 (50.7th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

N/a — versions n/a

Weakness classification (CWE)

CWE-331 — Insufficient Entropy

Public proof-of-concept exploits

Safecloudth/CVE-2024-53522

References

Frequently asked questions

What is CVE-2024-53522?: CVE-2024-53522 is a high-severity vulnerability in N/a, classified under Insufficient Entropy. CVSS score: 7.5/10. Published 2025-01-07.
How severe is CVE-2024-53522?: High severity. CVSS v3 base score is 7.5 out of 10.
Is CVE-2024-53522 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.